邵志敏教授，首批*長江學者特聘教授，復旦大學特聘教授。現任復旦大學腫瘤研究所長、乳腺癌研究所所長，大外科主任兼乳腺外科主任，中國抗癌協會乳腺癌專業委員會名譽主任委員，中華醫學會腫瘤學分會副主任委員，上海市抗癌協會乳腺癌專業委員會名譽主任委員，上海市醫學會腫瘤專科委員會主任委員，第八屆亞洲乳腺癌協會主席、St.Gallen乳腺癌大會專家團成員。主要從事乳腺癌的臨床和基礎研究，建立適合中國人群的早期篩查和診療流程，開展臨床試驗提高乳腺癌患者的預後，科研重點為乳腺癌的轉化研究和乳腺癌轉移機制研究等。已發表有關乳腺癌研究的論著近350篇，其中SCI收錄100餘篇，被世界醫學文獻引用逾3 000次，主編專著4本。多次榮獲衛生部科技進步一等獎，上海市科技進步一、二、三等獎，國家科技進步二等獎，*科技進步一、二等獎項。由其領銜的團隊分別入選*創新團隊、上海市乳腺腫瘤重點實驗室及上海市*“重中之重臨床醫學中心B類”項目、上海市重要疾病聯合攻關項目。先後主持國家傑出青年科研基金、國家自然科學基金、國家“十五”攻關課題、衛生部臨床重點項目、“211”工程II、“985”項目、“973”課題及其他省部級項目30餘項。
INTRODUCTION
Pro. Shao Zhimin, distinguished professor of Fudan University, is one of the first batch of distinguished professor of Chang Jiang Scholars. He presently serves as the director of Fudan University Cancer Institute and Breast Cancer Institute; chairman of department of surgery and department of breast surgery in Fudan University Cancer Hospital; Honorary chairman of Breast Cancer Society, China Anti-Cancer Association; Vice chairman of oncology branch committee, Chinese Medical Association; Honorary chairman of Breast Cancer Society, Shanghai Anti-Cancer Association; Chairman of oncology branch committee, Shanghai Medical Association; Chairman of the Eighth Asian Breast Cancer Society, and member of the St. Gallen international breast cancer consensus panel.
Prof.Shao engages in clinical and basic research for breast cancer. He established an early screening and diagnosis process for the Chinese population, and carry out clinical trials to improve the prognosis of breast cancer patients. His researches mainly focus on s breast cancer translational research and mechanisms of metastasis of breast cancer. He has published nearly 350 papers about breast cancer research, and over 100 of which is included by SCI and has been cited for more than 3000 times by the world’s medical literature. He also published four books about breast disease. Dr.Shao has been awarded with Prize of Science and Technology Progress of Ministry of Health, Grade I; Prize of Science and Technology Progress of Shanghai Government, Grade I, II and III; National Prize Prize of Science and Technology Progress, Grade II; and Prize of Science and Technology Progress of Ministry of Education, Grade I, II. He was chosen as leader of selected innovative team of the Ministry of Education, Shanghai Key Laboratory of Breast Malignancy Tumor, Shanghai Education Commission Type B Program of the Priority Project of Clinical Medical Centers, and the Shanghai Joint Research Project of Major Diseases. He hosted and actualized in over 30 key research projects including National Excellent Youth Foundation, National Science Foundation, Key Project of National 10th 5-year Plan, Priority project on clinical medicine of Ministry of Health, “211” Project phase II, “985” Project, “973” Project, and other provincial or ministerial projects.
